New Therapeutic Options in Congestive Heart Failure
- 7 May 2002
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation
- Vol. 105 (18) , 2223-2228
- https://doi.org/10.1161/01.cir.0000014771.38666.22
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Myocardial gene therapyNature, 2002
- Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart FailureNew England Journal of Medicine, 2001
- Guidelines for the diagnosis and treatment of chronic heart failureEuropean Heart Journal, 2001
- Changes in notions about heart failureThe Lancet, 2001
- What is the optimal medical management of ischemic heart failure?Progress in Cardiovascular Diseases, 2001
- Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodelingJournal of the American College of Cardiology, 2000
- Candesartan in heart failure—assessment of reduction in mortality and morbidity (CHARM): Rationale and designJournal of Cardiac Failure, 1999
- Racial differences in response to therapy for heart failure: Analysis of the vasodilator-heart failure trialsJournal of Cardiac Failure, 1999
- A controlled trial with a novel anti-ischemic agent, ranolazine, in chronic stable angina pectoris that is responsive to conventional antianginal agentsThe American Journal of Cardiology, 1999
- Congestive heart failure in subjects with normal versus reduced left ventricular ejection fractionJournal of the American College of Cardiology, 1999